Nexalin Technology Receives Nasdaq Listing Status Notification
HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq:…
Sharjah Achieves Historic WHO Age-Friendly Status
SHARJAH, UAE, Jan. 19, 2026 /PRNewswire/ -- The Emirate of Sharjah, UAE,…
GH Research to Announce IND Status for GH001
DUBLIN, Jan. 02, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS),…
Alvotech Provides Update on the Status ofU.S. Biologics License Application for AVT05
REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a…
Mactores Earns AWS Healthcare Competency Status, Enabling HIPAA-Compliant AI Solutions for Improved Patient Outcomes and Operational Excellence
Mactores has earned AWS Healthcare Competency, validating its expertise in automation-first, HIPAA-compliant…
Trianz Achieves AWS Premier Tier Status in the Amazon Web Services Partner Network
SANTA CLARA, Calif., Sept. 4, 2025 /PRNewswire/ -- Trianz, a digital transformation…
NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The New York Stock Exchange…
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and…
Hexaware Achieves AWS Premier Tier Status in the Amazon Web Services Partner Network
MUMBAI, India and ISELIN, N.J. , Sept. 2, 2025 /PRNewswire/ -- Hexaware…
Sirona Biochem Update to Shareholders on Financial Status and Operations
August 01, 2025 16:30 ET | Source: Sirona Biochem Corp. VANCOUVER, British…
